Crystal Tse
Stories by Crystal Tse
Chinese drug developer I-Mab Biopharma said to file for US IPO
The firm is working with financial advisers on the US share sale that could raise about $200 million.
Wanda Sports falls 36% in its trading debut after US IPO
The debut crash adds to the poor performance of Chinese companies that have gone public this year in the US.
Wanda’s downsized IPO marks another choppy US listing for Chinese firms
Instead of raising $500 million by selling 33.3 million ADS for $12-15 each, Wanda Sports is now shooting for 28 million shares at $9-11 to raise as m
China Merchants Shekou said to plan $800m REIT listing in HK
Shekou’s offering would be the first REIT listing in HK since Spring Real Estate Investment Trust raised $216 million in 2013.
Top Budweiser IPO banks said to lose up to $170m in fees
JPMorgan Chase & Co. and Morgan Stanley lost out on their cut of what would’ve been the year’s biggest IPO last week.
Netease said to seek at least $300m in US IPO of online education arm
A deal could value Youdao at about $2 billion.
AB InBev Asia unit may price its $9.8b HK IPO towards bottom
JPMorgan Chase & Co. and Morgan Stanley are joint sponsors for the Hong Kong share sale.
Chinese contract drugmaker Pharmaron plans HK listing to raise around $500m
The development comes only six months after the contract drugmaker went public in China.
Tencent-backed MUJI competitor MINISO mulls $1b IPO
The share sale could take place in Hong Kong or the U.S., while the timeline is yet to be decided.
China’s online pharmacy Ecmoho plans to raise $100m through US listing
The share sale could happen as soon as this year.
